Skip to main content
logo
Supernus Pharmaceuticals, Inc. (FRA:S49)
Germany flag Germany · Delayed Price · Currency is EUR
41.20
+0.60 (1.48%)
At close: Jan 27, 2026

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Treatment of Central Nervous System Diseases
661.82M
Treatment of Central Nervous System Diseases Growth
8.94%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States
661.82M
United States Growth
8.94%